- The NHS is rolling out a one-minute immunotherapy injection for over a dozen types of cancer, including lung, breast, and cervical cancer.
- This new injectable form of pembrolizumab (Keytruda) can reduce treatment time by up to 90 per cent compared to the previous intravenous drip method.
- Approximately 14,000 patients in England who start pembrolizumab therapy each year are expected to transition to the quicker jab.
- The innovation aims to free up significant NHS staff time, allowing more patients to be treated and potentially reducing waiting times.
- Patients, such as 89-year-old Shirley Xerxes who has bowel cancer, have already benefited from the new treatment, praising its convenience and speed.
IN FULL
